Wenzhou Medical University

high-precision BE for inherited blindness; prenatal editing.

Country
China
Coverage
CNEUUS
genome-engineering
Regulatorsfdaemanmpa
Technologies
NameClusterRisk
Base editinggenome-engineeringMedium

Compiled by BIOECON via the bioecon-brief pipeline.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.